Title : Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation - Fisher_2016_Value.Health_19_688 |
Author(s) : Fisher A , Carney G , Bassett K , Chappell NL |
Ref : Value Health , 19 :688 , 2016 |
Abstract :
BACKGROUND: In October 2007, British Columbia started to cover the cost of cholinesterase inhibitors (ChEIs)-donepezil, galantamine, and rivastigmine-for patients with mild to moderate dementia and prominent Alzheimer's disease. OBJECTIVES: To examine the impact of this policy on persistence with ChEIs. |
PubMedSearch : Fisher_2016_Value.Health_19_688 |
PubMedID: 27565287 |
Fisher A, Carney G, Bassett K, Chappell NL (2016)
Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation
Value Health
19 :688
Fisher A, Carney G, Bassett K, Chappell NL (2016)
Value Health
19 :688